Mitochondrial Transplantation Shows Promise in Heart Failure Patients
Pittsburgh cardiologists show that transplanting healthy mitochondria into failing heart tissue significantly improves cardiac function, opening new frontiers...
27 articles
Pittsburgh cardiologists show that transplanting healthy mitochondria into failing heart tissue significantly improves cardiac function, opening new frontiers...
A breakthrough in nanoparticle engineering enables efficient delivery of therapeutics across the blood-brain barrier, opening new possibilities for...
Cutting through the hype to examine what rigorous research tells us about fasting, time-restricted eating, and their effects on aging.
Why slow, steady aerobic exercise might be the most effective workout for healthspan and lifespan.
Stanford researchers demonstrate that brief, cyclic exposure to Yamanaka factors can reverse aging markers in human cells while maintaining cellular identity...
The first rigorous human trial of NMN supplementation shows meaningful benefits for age-related muscle decline.
Fourth-generation aging clock can predict mortality risk and response to interventions with remarkable accuracy.
AI platform screens billions of compounds to find promising senolytic molecules, compressing years of drug discovery into weeks.
The cellular rejuvenation startup backed by Jeff Bezos reveals its ambitious mission to reverse aging using reprogramming technology.
Investment in aging research continues to surge as institutional investors recognize the massive market opportunity.
The first rigorous human trial of the popular senolytic combination demonstrates measurable improvements in physical function and frailty markers.
Low-dose rapamycin improves vaccine response and reduces infections in older adults, suggesting broader anti-aging effects.